{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T21:23:35Z","timestamp":1766438615895,"version":"3.48.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372748"],"award-info":[{"award-number":["82372748"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972297"],"award-info":[{"award-number":["81972297"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chongqing Talent Project","award":["cstc2022ycjh-bgzxm0042"],"award-info":[{"award-number":["cstc2022ycjh-bgzxm0042"]}]},{"name":"Chongqing Young and Middle-Aged Medical Excellence Innovation Team Project","award":["yxgdrctd20210101"],"award-info":[{"award-number":["yxgdrctd20210101"]}]},{"name":"Chongqing Municipal Support Plan for Returning Overseas Students to Start Businesses and Innovate","award":["cx2024017"],"award-info":[{"award-number":["cx2024017"]}]},{"DOI":"10.13039\/501100012459","name":"Chongqing Graduate Student Research Innovation Project","doi-asserted-by":"publisher","award":["CYB240202"],"award-info":[{"award-number":["CYB240202"]}],"id":[{"id":"10.13039\/501100012459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality worldwide, underscoring the need for deeper insights into its molecular mechanisms. The SRY-box transcription factor 9 (SOX9) is a well-characterized oncoprotein critical for the pathogenesis and progression of multiple cancers, including NSCLC. However, the post-translational mechanisms governing SOX9 stability, particularly those mediated by arginine methyltransferases, are poorly defined. In this study, we identify protein arginine methyltransferase 7 (PRMT7) as a novel regulator of SOX9. We demonstrate that PRMT7 directly interacts with SOX9 and enhances its stability in a methyltransferase-dependent manner. Mechanistic investigations reveal that PRMT7 catalyzes mono-methylation of SOX9 at the arginine 160 (R160) residue, which in turn antagonizes SOX9 ubiquitination and subsequent proteasomal degradation mediated by the E3 ligases F-Box and WD repeat domain containing 7 (FBXW7) and kelch like ECH associated protein 1 (KEAP1). Functional assays revealed that PRMT7 promotes NSCLC cell proliferation in vitro and tumorigenesis in vivo in a SOX9-dependent manner. Consistent with these findings, clinical analysis revealed significant co-upregulation of both PRMT7 and SOX9 in NSCLC specimens relative to adjacent normal tissues, with elevated levels of either protein correlating with diminished patient survival. Collectively, our findings establish PRMT7 as a key regulator of SOX9 stability and function, thereby highlighting the PRMT7-SOX9 axis as a promising therapeutic target in NSCLC.<\/jats:p>","DOI":"10.1186\/s43556-025-00378-0","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T08:09:08Z","timestamp":1766390948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Protein arginine methyltransferase 7-mediated arginine mono-methylation stabilizes SRY-box transcription factor 9 to promote non-small cell lung cancer progression"],"prefix":"10.1186","volume":"6","author":[{"given":"Lin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyi","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yali","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gufang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianshu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunjia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7413-5934","authenticated-orcid":false,"given":"Chungang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"issue":"8","key":"378_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrc3775","volume":"14","author":"Z Chen","year":"2014","unstructured":"Chen Z, Fillmore CM, Hammerman PS, Kim CF, Wong KK. Non-small-cell lung cancers: a heterogeneous set of diseases. Nat Rev Cancer. 2014;14(8):535\u201346. https:\/\/doi.org\/10.1038\/nrc3775.","journal-title":"Nat Rev Cancer"},{"issue":"10212","key":"378_CR2","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1016\/S0140-6736(19)32795-3","volume":"394","author":"T Lancet","year":"2019","unstructured":"Lancet T. Lung cancer: some progress, but still a lot more to do. Lancet. 2019;394(10212):1880. https:\/\/doi.org\/10.1016\/S0140-6736(19)32795-3.","journal-title":"Lancet"},{"issue":"10066","key":"378_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","volume":"389","author":"FR Hirsch","year":"2017","unstructured":"Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ Jr, Wu YL, et al. Lung cancer: current therapies and new targeted treatments. Lancet. 2017;389(10066):299\u2013311. https:\/\/doi.org\/10.1016\/S0140-6736(16)30958-8.","journal-title":"Lancet"},{"key":"378_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.semcancer","volume":"89","author":"S Huang","year":"2023","unstructured":"Huang S, Yang J, Shen N, Xu Q, Zhao Q. Artificial intelligence in lung cancer diagnosis and prognosis: current application and future perspective. Semin Cancer Biol. 2023;89:30\u20137. https:\/\/doi.org\/10.1016\/j.semcancer.","journal-title":"Semin Cancer Biol"},{"issue":"8","key":"378_CR5","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/s41591-021-01450-2","volume":"27","author":"M Wang","year":"2021","unstructured":"Wang M, Herbst RS, Boshoff C. Toward personalized treatment approaches for non-small-cell lung cancer. Nat Med. 2021;27(8):1345\u201356. https:\/\/doi.org\/10.1038\/s41591-021-01450-2.","journal-title":"Nat Med"},{"issue":"8","key":"378_CR6","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1001\/jama.2019.11058","volume":"322","author":"KC Arbour","year":"2019","unstructured":"Arbour KC, Riely GJ. Systemic therapy for locally advanced and metastatic non-small cell lung cancer: a review. JAMA. 2019;322(8):764\u201374. https:\/\/doi.org\/10.1001\/jama.2019.11058.","journal-title":"JAMA"},{"issue":"10454","key":"378_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0140-6736(24)01029-8","volume":"404","author":"ML Meyer","year":"2024","unstructured":"Meyer ML, Fitzgerald BG, Paz-Ares L, Cappuzzo F, J\u00e4nne PA, Peters S, et al. New promises and challenges in the treatment of advanced non-small-cell lung cancer. Lancet. 2024;404(10454):803\u201322. https:\/\/doi.org\/10.1016\/S0140-6736(24)01029-8.","journal-title":"Lancet"},{"issue":"3","key":"378_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.molmed.2010","volume":"17","author":"J Pritchett","year":"2011","unstructured":"Pritchett J, Athwal V, Roberts N, Hanley NA, Hanley KP. Understanding the role of SOX9 in acquired diseases: lessons from development. Trends Mol Med. 2011;17(3):166\u201374. https:\/\/doi.org\/10.1016\/j.molmed.2010.","journal-title":"Trends Mol Med"},{"issue":"17","key":"378_CR9","doi-asserted-by":"publisher","first-page":"9106","DOI":"10.1093\/nar\/gky553","volume":"46","author":"M Girardot","year":"2018","unstructured":"Girardot M, Bayet E, Maurin J, Fort P, Roux P, Raynaud P. SOX9 has distinct regulatory roles in alternative splicing and transcription. Nucleic Acids Res. 2018;46(17):9106\u201318. https:\/\/doi.org\/10.1093\/nar\/gky553.","journal-title":"Nucleic Acids Res"},{"issue":"Pt 1","key":"378_CR10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.semcancer.2019.03.004","volume":"67","author":"D Grimm","year":"2020","unstructured":"Grimm D, Bauer J, Wise P, Kr\u00fcger M, Simonsen U, Wehland M, et al. The role of SOX family members in solid tumours and metastasis. Semin Cancer Biol. 2020;67(Pt 1):122\u201353. https:\/\/doi.org\/10.1016\/j.semcancer.2019.03.004.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"378_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1756-9966-31-18","volume":"31","author":"CH Zhou","year":"2012","unstructured":"Zhou CH, Ye LP, Ye SX, Li Y, Zhang XY, Xu XY, et al. Clinical significance of SOX9 in human non-small cell lung cancer progression and overall patient survival. J Exp Clin Cancer Res. 2012;31(1):18. https:\/\/doi.org\/10.1186\/1756-9966-31-18.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"378_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188517","volume":"1875","author":"M Panda","year":"2021","unstructured":"Panda M, Tripathi SK, Biswal BK. SOX9: an emerging driving factor from cancer progression to drug resistance. Biochim Biophys Acta Rev Cancer. 2021;1875(2):188517. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188517.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"18","key":"378_CR13","doi-asserted-by":"publisher","first-page":"8855","DOI":"10.1093\/nar\/gkw748","volume":"44","author":"X Hong","year":"2016","unstructured":"Hong X, Liu W, Song R, Shah JJ, Feng X, Tsang CK, et al. SOX9 is targeted for proteasomal degradation by the E3 ligase FBW7 in response to DNA damage. Nucleic Acids Res. 2016;44(18):8855\u201369. https:\/\/doi.org\/10.1093\/nar\/gkw748.","journal-title":"Nucleic Acids Res"},{"issue":"20","key":"378_CR14","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.15252\/embj.201693889","volume":"35","author":"A Suryo Rahmanto","year":"2016","unstructured":"Suryo Rahmanto A, Savov V, Brunner A, Bolin S, Weishaupt H, Malyukova A, et al. FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma. EMBO J. 2016;35(20):2192\u2013212. https:\/\/doi.org\/10.15252\/embj.201693889.","journal-title":"EMBO J"},{"issue":"21","key":"378_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202001018","volume":"7","author":"N Shao","year":"2020","unstructured":"Shao N, Huang H, Idris M, Peng X, Xu F, Dong S, et al. KEAP1 mutations drive tumorigenesis by suppressing SOX9 ubiquitination and degradation. Adv Sci. 2020;7(21):2001018. https:\/\/doi.org\/10.1002\/advs.202001018.","journal-title":"Adv Sci"},{"issue":"6","key":"378_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade5584","volume":"9","author":"Y Wu","year":"2023","unstructured":"Wu Y, Shen S, Chen J, Ni W, Wang Q, Zhou H, et al. Metabolite asymmetric dimethylarginine (ADMA) functions as a destabilization enhancer of SOX9 mediated by DDAH1 in osteoarthritis. Sci Adv. 2023;9(6):eade5584. https:\/\/doi.org\/10.1126\/sciadv.ade5584.","journal-title":"Sci Adv"},{"issue":"24","key":"378_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202206757","volume":"10","author":"Q Sun","year":"2023","unstructured":"Sun Q, Zhuang Z, Bai R, Deng J, Xin T, Zhang Y, et al. Lysine 68 methylation-dependent SOX9 stability control modulates chondrogenic differentiation in dental pulp stem cells. Adv Sci. 2023;10(24):e2206757. https:\/\/doi.org\/10.1002\/advs.202206757.","journal-title":"Adv Sci"},{"key":"378_CR18","doi-asserted-by":"publisher","unstructured":"Pei H, Chen L, Liao QM, Wang KJ, Chen SG, Liu ZJ, et al. SUMO-specific protease 2 (SENP2) functions as a tumor suppressor in osteosarcoma via SOX9 degradation. Exp Ther Med. 2018;16(6):5359\u201365.https:\/\/doi.org\/10.3892\/etm.2018.6838","DOI":"10.3892\/etm.2018.6838"},{"issue":"7","key":"378_CR19","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41573-021-00159-8","volume":"20","author":"Q Wu","year":"2021","unstructured":"Wu Q, Schapira M, Arrowsmith CH, Barsyte-Lovejoy D. Protein arginine methylation: from enigmatic functions to therapeutic targeting. Nat Rev Drug Discov. 2021;20(7):509\u201330. https:\/\/doi.org\/10.1038\/s41573-021-00159-8.","journal-title":"Nat Rev Drug Discov"},{"issue":"47","key":"378_CR20","doi-asserted-by":"publisher","first-page":"32604","DOI":"10.1074\/jbc.M114.609271","volume":"289","author":"Y Feng","year":"2014","unstructured":"Feng Y, Hadjikyriacou A, Clarke SG. Substrate specificity of human protein arginine methyltransferase 7 (PRMT7): the importance of acidic residues in the double E loop. J Biol Chem. 2014;289(47):32604\u201316. https:\/\/doi.org\/10.1074\/jbc.M114.609271.","journal-title":"J Biol Chem"},{"issue":"22","key":"378_CR21","doi-asserted-by":"publisher","first-page":"10603","DOI":"10.1093\/nar\/gkw788","volume":"44","author":"SH Lee","year":"2016","unstructured":"Lee SH, Chen TY, Dhar SS, Gu B, Chen K, Kim YZ, et al. A feedback loop comprising PRMT7 and miR-24-2 interplays with Oct4, Nanog, Klf4 and c-Myc to regulate stemness. Nucleic Acids Res. 2016;44(22):10603\u201318. https:\/\/doi.org\/10.1093\/nar\/gkw788.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"378_CR22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nsmb.2209","volume":"19","author":"V Migliori","year":"2012","unstructured":"Migliori V, M\u00fcller J, Phalke S, Low D, Bezzi M, Mok WC, et al. Symmetric dimethylation of H3R2 is a newly identified histone mark that supports euchromatin maintenance. Nat Struct Mol Biol. 2012;19(2):136\u201344. https:\/\/doi.org\/10.1038\/nsmb.2209.","journal-title":"Nat Struct Mol Biol"},{"issue":"10","key":"378_CR23","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/s41580-019-0155-x","volume":"20","author":"E Guccione","year":"2019","unstructured":"Guccione E, Richard S. The regulation, functions and clinical relevance of arginine methylation. Nat Rev Mol Cell Biol. 2019;20(10):642\u201357. https:\/\/doi.org\/10.1038\/s41580-019-0155-x.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"13","key":"378_CR24","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.scib.2021.01.004","volume":"66","author":"HH Wei","year":"2021","unstructured":"Wei HH, Fan XJ, Hu Y, Tian XX, Guo M, et al. A systematic survey of PRMT interactomes reveals the key roles of arginine methylation in the global control of RNA splicing and translation. Sci Bull (Beijing). 2021;66(13):1342\u201357. https:\/\/doi.org\/10.1016\/j.scib.2021.01.004.","journal-title":"Sci Bull (Beijing)"},{"issue":"11","key":"378_CR25","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.molmed.2019.05.007","volume":"25","author":"J Jarrold","year":"2019","unstructured":"Jarrold J, Davies CC. PRMTs and arginine methylation: cancer\u2019s best-kept secret? Trends Mol Med. 2019;25(11):993\u20131009. https:\/\/doi.org\/10.1016\/j.molmed.2019.05.007.","journal-title":"Trends Mol Med"},{"issue":"10","key":"378_CR26","doi-asserted-by":"publisher","first-page":"5511","DOI":"10.1093\/nar\/gkaa211","volume":"48","author":"TR Ferreira","year":"2020","unstructured":"Ferreira TR, Dowle AA, Parry E, Alves-Ferreira EVC, Hogg K, Kolokousi F, et al. PRMT7 regulates RNA-binding capacity and protein stability in Leishmania parasites. Nucleic Acids Res. 2020;48(10):5511\u201326. https:\/\/doi.org\/10.1093\/nar\/gkaa211.","journal-title":"Nucleic Acids Res"},{"issue":"35","key":"378_CR27","doi-asserted-by":"publisher","first-page":"29801","DOI":"10.1074\/jbc.M112.378281","volume":"287","author":"V Karkhanis","year":"2012","unstructured":"Karkhanis V, Wang L, Tae S, Hu YJ, Imbalzano AN, Sif S. Protein arginine methyltransferase 7 regulates cellular response to DNA damage by methylating promoter histones H2A and H4 of the polymerase \u03b4 catalytic subunit gene, POLD1. J Biol Chem. 2012;287(35):29801\u201314. https:\/\/doi.org\/10.1074\/jbc.M112.378281.","journal-title":"J Biol Chem"},{"issue":"1","key":"378_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.molcel.2016.11.003","volume":"65","author":"RS Blanc","year":"2017","unstructured":"Blanc RS, Richard S. Arginine methylation: the coming of age. Mol Cell. 2017;65(1):8\u201324. https:\/\/doi.org\/10.1016\/j.molcel.2016.11.003.","journal-title":"Mol Cell"},{"issue":"6","key":"378_CR29","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.cmet.2022.04.004","volume":"34","author":"C Liu","year":"2022","unstructured":"Liu C, Zou W, Nie D, Li S, Duan C, Zhou M, et al. Loss of PRMT7 reprograms glycine metabolism to selectively eradicate leukemia stem cells in CML. Cell Metab. 2022;34(6):818-35.e7. https:\/\/doi.org\/10.1016\/j.cmet.2022.04.004.","journal-title":"Cell Metab"},{"issue":"6","key":"378_CR30","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1091\/mbc.E18-05-0330","volume":"30","author":"N Haghandish","year":"2019","unstructured":"Haghandish N, Baldwin RM, Morettin A, Dawit HT, Adhikary H, Masson JY, et al. PRMT7 methylates eukaryotic translation initiation factor 2\u03b1 and regulates its role in stress granule formation. Mol Biol Cell. 2019;30(6):778\u201393. https:\/\/doi.org\/10.1091\/mbc.E18-05-0330.","journal-title":"Mol Biol Cell"},{"issue":"1","key":"378_CR31","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1038\/s41467-020-16271-z","volume":"11","author":"MM Szewczyk","year":"2020","unstructured":"Szewczyk MM, Ishikawa Y, Organ S, Sakai N, Li F, Halabelian L, et al. Pharmacological inhibition of PRMT7 links arginine monomethylation to the cellular stress response. Nat Commun. 2020;11(1):2396. https:\/\/doi.org\/10.1038\/s41467-020-16271-z.","journal-title":"Nat Commun"},{"key":"378_CR32","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/srep00805","volume":"2","author":"RK Bikkavilli","year":"2012","unstructured":"Bikkavilli RK, Avasarala S, Vanscoyk M, Sechler M, Kelley N, Malbon CC, et al. Dishevelled3 is a novel arginine methyl transferase substrate. Sci Rep. 2012;2:805. https:\/\/doi.org\/10.1038\/srep00805.","journal-title":"Sci Rep"},{"key":"378_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2020.105686","volume":"120","author":"F Liu","year":"2020","unstructured":"Liu F, Wan L, Zou H, Pan Z, Zhou W, Lu X. PRMT7 promotes the growth of renal cell carcinoma through modulating the \u03b2-catenin\/C-MYC axis. Int J Biochem Cell Biol. 2020;120:105686. https:\/\/doi.org\/10.1016\/j.biocel.2020.105686.","journal-title":"Int J Biochem Cell Biol"},{"key":"378_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101144","volume":"77","author":"SC Lin","year":"2024","unstructured":"Lin SC, Tsai YC, Chen YL, Lin HK, Huang YC, Lin YS, et al. Un-methylation of NUDT21 represses docosahexaenoic acid biosynthesis contributing to enzalutamide resistance in prostate cancer. Drug Resist Updat. 2024;77:101144. https:\/\/doi.org\/10.1016\/j.drup.2024.101144.","journal-title":"Drug Resist Updat"},{"key":"378_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.117103","volume":"283","author":"GJ Yang","year":"2025","unstructured":"Yang GJ, Liu YJ, Chen RY, Shi JJ, Li CY, Wang R, et al. PRMT7 in cancer: structure, effects, and therapeutic potentials. Eur J Med Chem. 2025;283:117103. https:\/\/doi.org\/10.1016\/j.ejmech.2024.117103.","journal-title":"Eur J Med Chem"},{"issue":"15","key":"378_CR36","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.7150\/jca.88102","volume":"14","author":"X Wang","year":"2023","unstructured":"Wang X, Xu W, Zhu C, Cheng Y, Qi J. PRMT7 inhibits the proliferation and migration of gastric cancer cells by suppressing the PI3K\/AKT pathway via PTEN. J Cancer. 2023;14(15):2833\u201344. https:\/\/doi.org\/10.7150\/jca.88102.","journal-title":"J Cancer"},{"issue":"1","key":"378_CR37","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1038\/s41467-021-21963-1","volume":"12","author":"WJ Li","year":"2021","unstructured":"Li WJ, He YH, Yang JJ, Hu GS, Lin YA, Ran T, et al. Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth. Nat Commun. 2021;12(1):1946. https:\/\/doi.org\/10.1038\/s41467-021-21963-1.","journal-title":"Nat Commun"},{"issue":"5","key":"378_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0285812","volume":"18","author":"TJ Bondoc","year":"2023","unstructured":"Bondoc TJ, Lowe TL, Clarke SG. The exquisite specificity of human protein arginine methyltransferase 7 (PRMT7) toward Arg-X-Arg sites. PLoS ONE. 2023;18(5):e0285812. https:\/\/doi.org\/10.1371\/journal.pone.0285812.","journal-title":"PLoS ONE"},{"key":"378_CR39","doi-asserted-by":"publisher","first-page":"4869","DOI":"10.2147\/OTT.S166412","volume":"11","author":"D Cheng","year":"2018","unstructured":"Cheng D, He Z, Zheng L, Xie D, Dong S, Zhang P. PRMT7 contributes to the metastasis phenotype in human non-small-cell lung cancer cells possibly through the interaction with HSPA5 and EEF2. Onco Targets Ther. 2018;11:4869\u201376. https:\/\/doi.org\/10.2147\/OTT.S166412.","journal-title":"Onco Targets Ther"},{"issue":"5","key":"378_CR40","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s12276-021-00613-y","volume":"53","author":"JW Hwang","year":"2021","unstructured":"Hwang JW, Cho Y, Bae GU, Kim SN, Kim YK. Protein arginine methyltransferases: promising targets for cancer therapy. Exp Mol Med. 2021;53(5):788\u2013808. https:\/\/doi.org\/10.1038\/s12276-021-00613-y.","journal-title":"Exp Mol Med"},{"issue":"1","key":"378_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrc3409","volume":"13","author":"Y Yang","year":"2013","unstructured":"Yang Y, Bedford MT. Protein arginine methyltransferases and cancer. Nat Rev Cancer. 2013;13(1):37\u201350. https:\/\/doi.org\/10.1038\/nrc3409.","journal-title":"Nat Rev Cancer"},{"issue":"443","key":"378_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aaf7329","volume":"9","author":"SC Larsen","year":"2016","unstructured":"Larsen SC, Sylvestersen KB, Mund A, Lyon D, Mullari M, Madsen MV, et al. Proteome-wide analysis of arginine monomethylation reveals widespread occurrence in human cells. Sci Signal. 2016;9(443):rs9. https:\/\/doi.org\/10.1126\/scisignal.aaf7329.","journal-title":"Sci Signal"},{"issue":"5","key":"378_CR43","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1158\/0008-5472.CAN-11-3660","volume":"72","author":"A Matheu","year":"2012","unstructured":"Matheu A, Collado M, Wise C, Manterola L, Cekaite L, Tye AJ, et al. Oncogenicity of the developmental transcription factor Sox9. Cancer Res. 2012;72(5):1301\u201315. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-3660.","journal-title":"Cancer Res"},{"issue":"1","key":"378_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13058-021-01435-6","volume":"23","author":"KN Al-Zahrani","year":"2021","unstructured":"Al-Zahrani KN, Abou-Hamad J, Pascoal J, Labr\u00e8che C, Garland B, Sabourin LA. AKT-mediated phosphorylation of Sox9 induces Sox10 transcription in a murine model of HER2-positive breast cancer. Breast Cancer Res. 2021;23(1):55. https:\/\/doi.org\/10.1186\/s13058-021-01435-6.","journal-title":"Breast Cancer Res"},{"key":"378_CR45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1471-213X-9-47","volume":"9","author":"T Ito","year":"2009","unstructured":"Ito T, Yadav N, Lee J, Furumatsu T, Yamashita S, Yoshida K, et al. Arginine methyltransferase CARM1\/PRMT4 regulates endochondral ossification. BMC Dev Biol. 2009;9:47. https:\/\/doi.org\/10.1186\/1471-213X-9-47.","journal-title":"BMC Dev Biol"},{"issue":"35","key":"378_CR46","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1038\/onc.2009.168","volume":"28","author":"FJ Swartling","year":"2009","unstructured":"Swartling FJ, Ferletta M, Kastemar M, Weiss WA, Westermark B. Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines. Oncogene. 2009;28(35):3121\u201331. https:\/\/doi.org\/10.1038\/onc.2009.168.","journal-title":"Oncogene"},{"issue":"12","key":"378_CR47","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/s41416-019-0625-0","volume":"121","author":"Y Xue","year":"2019","unstructured":"Xue Y, Lian W, Zhi J, Yang W, Li Q, Guo X, et al. HDAC5-mediated deacetylation and nuclear localisation of SOX9 is critical for tamoxifen resistance in breast cancer. Br J Cancer. 2019;121(12):1039\u201349. https:\/\/doi.org\/10.1038\/s41416-019-0625-0.","journal-title":"Br J Cancer"},{"issue":"10","key":"378_CR48","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1210\/me.2004-0173","volume":"18","author":"T Komatsu","year":"2004","unstructured":"Komatsu T, Mizusaki H, Mukai T, Ogawa H, Baba D, Shirakawa M, et al. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein\/steroidogenic factor 1 (Ad4BP\/SF-1) regulates synergistic transcription between Ad4BP\/SF-1 and Sox9. Mol Endocrinol. 2004;18(10):2451\u201362. https:\/\/doi.org\/10.1210\/me.2004-0173.","journal-title":"Mol Endocrinol"},{"issue":"4","key":"378_CR49","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1172\/JCI90193","volume":"127","author":"AT Egunsola","year":"2017","unstructured":"Egunsola AT, Bae Y, Jiang MM, Liu DS, Chen-Evenson Y, Bertin T, et al. Loss of DDRGK1 modulates SOX9 ubiquitination in spondyloepimetaphyseal dysplasia. J Clin Invest. 2017;127(4):1475\u201384. https:\/\/doi.org\/10.1172\/JCI90193.","journal-title":"J Clin Invest"},{"key":"378_CR50","doi-asserted-by":"publisher","DOI":"10.34133\/research.0549","volume":"8","author":"S Meng","year":"2025","unstructured":"Meng S, Liu H, Xu J, Deng C, Qian X, Chu S, et al. PRMT5-mediated ALKBH5 methylation promotes colorectal cancer immune evasion via increasing CD276 expression. Research. 2025;8:0549. https:\/\/doi.org\/10.34133\/research.0549.","journal-title":"Research"},{"key":"378_CR51","doi-asserted-by":"publisher","first-page":"8419","DOI":"10.1038\/ncomms9419","volume":"6","author":"D Hu","year":"2015","unstructured":"Hu D, Gur M, Zhou Z, Gamper A, Hung MC, Fujita N, et al. Interplay between arginine methylation and ubiquitylation regulates KLF4-mediated genome stability and carcinogenesis. Nat Commun. 2015;6:8419. https:\/\/doi.org\/10.1038\/ncomms9419.","journal-title":"Nat Commun"},{"issue":"2","key":"378_CR52","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201948597","volume":"21","author":"J Liu","year":"2020","unstructured":"Liu J, Feng J, Li L, Lin L, Ji J, Lin C, et al. Arginine methylation-dependent LSD1 stability promotes invasion and metastasis of breast cancer. EMBO Rep. 2020;21(2):e48597. https:\/\/doi.org\/10.15252\/embr.201948597.","journal-title":"EMBO Rep"},{"issue":"7","key":"378_CR53","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41419-024-06920-2","volume":"15","author":"J Wang","year":"2024","unstructured":"Wang J, Shen S, You J, Wang Z, Li Y, Chen Y, et al. PRMT6 facilitates EZH2 protein stability by inhibiting TRAF6-mediated ubiquitination degradation to promote glioblastoma cell invasion and migration. Cell Death Dis. 2024;15(7):524. https:\/\/doi.org\/10.1038\/s41419-024-06920-2.","journal-title":"Cell Death Dis"},{"issue":"20","key":"378_CR54","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1038\/onc.2010.610","volume":"30","author":"B Cha","year":"2011","unstructured":"Cha B, Kim W, Kim YK, Hwang BN, Park SY, Yoon JW, et al. Methylation by protein arginine methyltransferase 1 increases stability of Axin, a negative regulator of Wnt signaling. Oncogene. 2011;30(20):2379\u201389. https:\/\/doi.org\/10.1038\/onc.2010.610.","journal-title":"Oncogene"},{"issue":"6","key":"378_CR55","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1096\/fj.201601196R","volume":"31","author":"P Geng","year":"2017","unstructured":"Geng P, Zhang Y, Liu X, Zhang N, Liu Y, Liu X, et al. Automethylation of protein arginine methyltransferase 7 and its impact on breast cancer progression. FASEB J. 2017;31(6):2287\u2013300. https:\/\/doi.org\/10.1096\/fj.201601196R.","journal-title":"FASEB J"},{"issue":"1","key":"378_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28861-0","volume":"13","author":"T Shen","year":"2022","unstructured":"Shen T, Ni T, Chen J, Chen H, Ma X, Cao G, et al. An enhancer variant at 16q22.1 predisposes to hepatocellular carcinoma via regulating PRMT7 expression. Nat Commun. 2022;13(1):1232. https:\/\/doi.org\/10.1038\/s41467-022-28861-0.","journal-title":"Nat Commun"},{"issue":"8","key":"378_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/life11080768","volume":"11","author":"L Halabelian","year":"2021","unstructured":"Halabelian L, Barsyte-Lovejoy D. Structure and function of protein arginine methyltransferase PRMT7. Life (Basel). 2021;11(8):768. https:\/\/doi.org\/10.3390\/life11080768.","journal-title":"Life (Basel)"},{"issue":"8","key":"378_CR58","doi-asserted-by":"publisher","first-page":"8244","DOI":"10.1021\/acs.jmedchem.4c02978","volume":"68","author":"J Li","year":"2025","unstructured":"Li J, Sun C, Zhang Y, Ding J, Yao P, Shen H, et al. Development of novel PRMT7 inhibitors for the treatment of prostate cancer. J Med Chem. 2025;68(8):8244\u201368. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c02978.","journal-title":"J Med Chem"},{"issue":"1","key":"378_CR59","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/s41467-025-56564-9","volume":"16","author":"N Shao","year":"2025","unstructured":"Shao N, Xi L, Lv Y, Idris M, Zhang L, Cao Y, et al. USP5 stabilizes YTHDF1 to control cancer immune surveillance through mTORC1-mediated phosphorylation. Nat Commun. 2025;16(1):1313. https:\/\/doi.org\/10.1038\/s41467-025-56564-9.","journal-title":"Nat Commun"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00378-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-025-00378-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00378-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T20:02:23Z","timestamp":1766433743000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-025-00378-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["378"],"URL":"https:\/\/doi.org\/10.1186\/s43556-025-00378-0","relation":{},"ISSN":["2662-8651"],"issn-type":[{"type":"electronic","value":"2662-8651"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments in this study were approved by the Ethics of the Second Affiliated Hospital of Chongqing Medical University (approval No. IACUC-SAHCQMU-2024-00180).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"148"}}